We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

157 hedge funds and large institutions have $817M invested in Intersect ENT, Inc in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more call options, than puts

Call options by funds: $5.8M | Put options by funds: $696K

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

12% more funds holding

Funds holding: 140157 (+17)

4% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 52

3% more capital invested

Capital invested by funds: $792M → $817M (+$25.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
157
Holders Change
+17
Holders Change %
+12.14%
% of All Funds
3.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
54
Reduced
52
Closed
12
Calls
$5.8M
Puts
$696K
Net Calls
+$5.1M
Net Calls Change
+$322K
Name Holding Trade Value Shares
Change
Change in
Stake
AR
51
Advisory Research
Illinois
$2.4M +$824K +27,480 +59%
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
$2.28M +$2.11M +70,307 New
QI
53
QS Investors
New York
$2.14M -$15.3K -511 -0.8%
CCMH
54
Cornerstone Capital Management Holdings
New York
$1.97M -$129K -4,300 -7%
FG
55
Formula Growth
Quebec, Canada
$1.92M
PP
56
PDT Partners
New York
$1.83M -$383K -12,780 -18%
AMI
57
Amica Mutual Insurance
Rhode Island
$1.78M
Goldman Sachs
58
Goldman Sachs
New York
$1.57M -$1.25M -41,812 -46%
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$1.55M +$1.35M +45,146 +1,676%
GCP
60
GSA Capital Partners
United Kingdom
$1.52M +$515K +17,172 +58%
AQR Capital Management
61
AQR Capital Management
Connecticut
$1.52M +$875K +29,172 +165%
USAA
62
United Services Automobile Association
Texas
$1.48M +$90.6K +3,021 +7%
LCG
63
Lisanti Capital Growth
New York
$1.47M +$815K +27,165 +151%
Mackenzie Financial
64
Mackenzie Financial
Ontario, Canada
$1.41M +$36.6K +1,220 +3%
ARTA
65
A.R.T. Advisors
New York
$1.39M -$1.02M -33,900 -44%
Swiss National Bank
66
Swiss National Bank
Switzerland
$1.39M
TRSOTSOK
67
Teachers Retirement System of the State of Kentucky
Kentucky
$1.38M +$50.9K +1,696 +4%
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
$1.36M +$16.1K +537 +1%
BG
69
Bellevue Group
Switzerland
$1.25M -$77.1K -2,570 -6%
PPA
70
Parametric Portfolio Associates
Washington
$1.19M -$2.12M -70,636 -66%
Two Sigma Advisers
71
Two Sigma Advisers
New York
$1.17M +$747K +24,900 +222%
EGI
72
EAM Global Investors
California
$1.16M +$1.07M +35,645 New
APFBOT
73
Amica Pension Fund Board of Trustees
Rhode Island
$1.1M
TAM
74
Tiverton Asset Management
Delaware
$1.08M -$499K -16,634 -33%
HI
75
HBK Investments
Texas
$1.08M -$7.59K -253 -0.8%

XENT Hedge Fund Activity: Q4 2017 in Review

157 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2017, worth a combined $817M — up 3.2% from $792M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XENT positions and 12 closed out — a net gain of 17 holders — while 54 added to existing stakes and 52 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $15.3M. The largest seller was Fidelity Investments, cutting an estimated $33.6M.

  • 157 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2017, up from 140 in Q3 2017.
  • Funds reported $817M of Intersect ENT, Inc stock for Q4 2017, up 3.2% quarter-over-quarter.
  • 29 funds opened new Intersect ENT, Inc positions in Q4 2017 and 12 closed out, a net change of +17 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2017 was Point72 Asset Management, an estimated $15.3M added.
  • The largest Intersect ENT, Inc seller in Q4 2017 was Fidelity Investments, an estimated $33.6M sold.

Based on aggregated 13F filings for Q4 2017.